Elon Musk says he prefers Lilly’s Mounjaro over Novo’s Ozempic
CEO's newfound preference for Eli Lilly's (NYSE:LLY) weight loss therapy Mounjaro over Novo Nordisk's (NVO) rival product ...
Does This News From the FDA Make Eli Lilly a Buy for 2025?
In a recent head-to-head study involving Novo Nordisk 's Wegovy, Zepbound came out on top, resulting in average weight loss ...
bovnews11d
How Does Eli Lilly And Co (LLY) Stack Up Against Its Industry Peers?
Eli Lilly And Co (LLY) stock saw a modest uptick, ending the day at $789.12 which represents a slight increase of $6.77 or 0.87% from the prior close of $782.35. The stock opened at $777.13 and ...
bovnews6d
Eli Lilly And Co (LLY) Stock: Greater Than Its Current Valuation?
Eli Lilly And Co (LLY) stock saw a decline, ending the day at $764.71 which represents a decrease of $-13.91 or -1.79% from the prior close of $778.62. The stock opened at $775 and touched a low of ...